Neuromuscular electrical stimulation prevents muscle function deterioration in exacerbated COPD: a pilot study

Area of Science:

• Respiratory Medicine
• Rehabilitation Science
• Muscle Physiology

Background:

• Peripheral muscle dysfunction is a significant issue in COPD, impacting exercise capacity, quality of life, and mortality.
• Pulmonary rehabilitation (PR) improves outcomes in COPD by enhancing muscle function, but muscle deterioration continues during severe exacerbations (SECOPD) before PR begins.

Purpose of the Study:

• To assess the feasibility and efficacy of quadriceps neuromuscular electrical stimulation (NMES) during SECOPD.
• To determine if NMES can prevent muscle function decline in COPD patients during hospitalization for SECOPD.

Main Methods:

• A pilot study involving 11 COPD patients hospitalized with SECOPD.
• One quadriceps leg received daily NMES for 14 days, while the other served as a non-stimulated control.
• Primary outcome measured was the change in quadriceps maximal voluntary contraction (ΔQMVC).

Main Results:

• Quadriceps muscle strength decreased in control legs but significantly increased in NMES-stimulated legs (p < 0.01).
• The difference in strength change between stimulated and control legs was statistically significant (p < 0.05).
• NMES efficacy correlated with stimulation intensity (r = 0.76, p < 0.01), and all patients tolerated the treatment well.

Conclusions:

• NMES is a feasible and effective intervention to prevent quadriceps muscle strength loss during SECOPD.
• NMES may serve as an adjunct therapy to early pulmonary rehabilitation programs for COPD patients.